特朗普：我们将在不久的将来宣布对药品征收关税。

Core Viewpoint - The announcement of tariffs on pharmaceuticals is expected to be made by Trump in the near future, indicating a potential shift in trade policy that could impact the pharmaceutical industry significantly [1] Group 1 - The upcoming tariffs on drugs may lead to increased costs for pharmaceutical companies, affecting their pricing strategies and profit margins [1] - This policy change could also influence the supply chain dynamics within the pharmaceutical sector, as companies may need to adjust their sourcing and distribution strategies to mitigate the impact of tariffs [1] - The announcement reflects a broader trend of protectionist measures that could reshape the competitive landscape of the pharmaceutical industry [1]